Our program is well suited to generate the needed investigators for multi-disciplinary training. We have specific training programs for clinically trained physician postdoctoral investigators and research trained PhD postdoctoral investigators. To facilitate the development of a cohesive training environment we integrate the three major cardiovascular research centers at the University of Utah School of Medicine: The University of Utah Molecular Medicine Program at the Eccles Institute of Human Genetics, Heart Failure and Regeneration Initiatives in the Divisions of Cardiology and Cardiothoracic Surgery at the School of Medicine, Nora Eccles Harrison Cardiovascular Research and Training Institute that specializes in cardiac electrophysiology and ion transport. These three centers of cardiovascular research are located near to one another on our campus and form the three legs of a tripod that support the T32 in Cardiovascular Research. Nineteen members of the faculty of the School of Medicine will form the 'core training faculty'for the program. All are experts in their fields and are successful in training post doctoral fellows. We wish to support eight post-doctoral MD and PhD scientist-trainees each year. We anticipate that each trainee will be supported for a minimum of two years by the T32.
The basis for this program's existence and continuation is the need for well-trained investigators in cardiovascular medicine. There are too few well trained cardiovascular investigators to take advantage of today's enormous growth in genetics, imaging, and technological advances. The University of Utah has successfully trained cardiovascular investigators and is well-equipped to continue this success.
|Petersen, Mark E; Jacobsen, Michael T; Kay, Michael S (2016) Synthesis of tumor necrosis factor Î± for use as a mirror-image phage display target. Org Biomol Chem 14:5298-303|
|Flygare, Steven; Simmon, Keith; Miller, Chase et al. (2016) Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling. Genome Biol 17:111|
|Jacobsen, Michael T; Petersen, Mark E; Ye, Xiang et al. (2016) A Helping Hand to Overcome Solubility Challenges in Chemical Protein Synthesis. J Am Chem Soc 138:11775-82|
|Gibson, Christopher C; Zhu, Weiquan; Davis, Chadwick T et al. (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131:289-99|
|Walker, Ashley E; Henson, Grant D; Reihl, Kelly D et al. (2015) Greater impairments in cerebral artery compared with skeletal muscle feed artery endothelial function in a mouse model of increased large artery stiffness. J Physiol 593:1931-43|
|Selzman, Craig H; Madden, Jesse L; Healy, Aaron H et al. (2015) Bridge to removal: a paradigm shift for left ventricular assist device therapy. Ann Thorac Surg 99:360-7|
|Wende, Adam R; O'Neill, Brian T; Bugger, Heiko et al. (2015) Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes. Mol Cell Biol 35:831-46|
|Yu, Jinlong; Zhang, Xuefeng; Kuzontkoski, Paula M et al. (2014) Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway. Cell Commun Signal 12:25|
|Lopez-Izquierdo, Angelica; Warren, Mark; Riedel, Michael et al. (2014) A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 307:H1370-7|
|Abdullah, Osama M; Drakos, Stavros G; Diakos, Nikolaos A et al. (2014) Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed 27:1378-86|
Showing the most recent 10 out of 80 publications